Abstract format

  • Before starting abstract submission, read the Instructions and Guidelines!
  • Prepare your abstract in a Microsoft Word document to be copied and pasted during abstract submission.
  • Abstract body (including Title, Authors, Affiliation, and Financial Support Information) should NOT exceed 3600 characters (including spaces). Indicate the institution of each author.
  • Capitalize only the Initial Letters in the Abstract Title. For example: Gastroprotective Effect of Lonchocarpus sericeus on Ethanol-Induced Gastric Lesion in Mice: Role of Prostaglandins and Nitric Oxide.
  • Use standard abbreviations for units of measure. Other abbreviations should be spelled out in full at first mention, followed by the abbreviation in parentheses. Exceptions: AMPc, EGTA, DNA, RNA etc. 
  • The abstracts must be divided into: Introduction, Methods, Results, and Conclusion. Financial Support and the approval by Human or Animal Research Ethical Committee should be included, when applied.
  • References: Quote the first author, abbreviated journal, volume, first page and year. For example: Kahn, RS. Nat. Rev. Dis. Prim., v. 1, p. 1, 2015.
  • DO NOT include tables or figures. DO NOT underline, italicize, except for scientific names, or embolden any word. 
  • Allocate the Acknowledgments at the end of the abstract.
  • Important: When applicable, approval by Human or Animal Research Ethical Committee and the financial support MUST be indicated. The absence of both information will not allow the abstract submission to be completed. In case of any doubt, contact SBFTE secretariat (sbfte@sbfte.org.br).
  • Projects will not be accepted. 
  • For authors DO NOT USE as a surname: Filho, Sobrinho, Neto, or Junior. Use for example: Carvalho-Júnior, Silva Neto JA.

Online abstract submission

  • Abstracts should be submitted electronically from March 24th to June 5th, 2023 (11:59 PM BRT).
  • Only Abstracts in English will be accepted.
  • Only ONE abstract per registration (author or coauthor) will be accepted.
  • All submitted abstracts will be evaluated by an Abstract Evaluation Committee.
  • By default, all approved abstracts will be considered for a poster presentation.
  • If you are an Undergraduate or Graduate Student (Master or Doctoral Degree): Indicate during online abstract submission your preference to be considered for an Oral Communication. The Oral Communication must be in English.
  • The Scientific Program Committee reserves the right to select few abstracts for Oral Communications. 
  • Abstracts presented as Oral Communications will also have to be presented as posters. Only first authors are allowed to deliver the Oral Communication.
  • Graduate Student (Master or Doctoral Degree) or a young researcher who want to submit for José Ribeiro do Valle (JRV) Award see rules here.
  • Undergraduate Students and Graduate Students (members and nonmembers): The advisor/supervisor will receive an E-mail to confirm the student status when submitting abstract and/or registering online.
  • Click on Online Registration to begin your abstract submission
  • Attention: After abstract submission, no alteration of the title and authors’ names will be allowed.

Abstract/Posters Categories

01. Cellular and Molecular Pharmacology

02. Neuropharmacology

03. Psychopharmacology

04. Inflammation and Immunopharmacology

05. Pain and Nociception Pharmacology

06. Cardiovascular and Renal Pharmacology

07. Endocrine, Reproductive and Urinary Pharmacology

08. Respiratory and Gastrointestinal Pharmacology

09. Natural Products and Toxinology

10. Cancer Pharmacology

11. Clinical Pharmacology, Pharmacokinetics, Pharmacogenomics and Toxicology

12. Drug Discovery and Development

13. Pharmacology Education and Technology

14. Pharmacology: Other